Document is current
Any future updates will be listed below
-
Authors
Sankar, Venkat
Hung, King L.
Gnanasekar, Aditi
Wong, Ivy Tsz-Lo https://orcid.org/0000-0002-9761-3422
Shi, Quanming
Kraft, Katerina
Jones, Matthew G.
He, Britney Jiayu
Yan, Xiaowei https://orcid.org/0000-0002-4846-8812
Belk, Julia A. https://orcid.org/0000-0003-4724-6158
Liu, Kevin J. https://orcid.org/0000-0003-3836-3213
Agarwal, Sangya https://orcid.org/0000-0003-4272-515X
Wang, Sean K. https://orcid.org/0000-0003-1557-8510
Henssen, Anton G. https://orcid.org/0000-0003-1534-778X
Mischel, Paul S. https://orcid.org/0000-0002-4560-2211
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
- License Information
-
More Information
Article History
Received: 5 September 2024
Accepted: 15 October 2025
First Online: 19 November 2025
Competing interests
: H.Y.C. is an employee and stockholder of Amgen as of 16 December 2024. H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics, and was an advisor of Arsenal Biosciences, Chroma Medicine, Exai Bio and Vida Ventures until 15 December 2024. P.S.M. is a co-founder and advisor of Boundless Bio. A.G.H. is a founder and shareholder of Econic Biosciences. M.G.J. is a consultant for and holds equity in Vevo Therapeutics. The remaining authors declare no competing interests.
